TheEdgeResearch
Home / Stocks / IART

Integra LifeSciences Holdings Corporation (IART)

NASDAQ Healthcare Medical - Devices
$17.24 ▼ -0.74%
Market Cap
$1.34B
Sector
Healthcare
Industry
Medical - Devices
Beta
1.21
52-Wk Range
8.7-20.49
CEO
Stuart Essig
Country
US
Currency
USD

Integra LifeSciences Holdings Corporation operates in the Medical - Devices industry of the Healthcare sector, headquartered in Princeton, NJ, US. The stock last traded at $17.24, down 0.74% on the session, giving a market capitalisation of $1.34B. On trailing twelve-month figures it carries a trailing P/E of -187.01, a net margin of -0.4%. Its beta of 1.21 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-187.01
Price / Sales
0.81
Price / Book
1.28
EV / EBITDA
15.03
Gross margin
53.7%
Operating margin
39.8%
Net margin
-0.4%
Return on equity
Debt / equity
1.94
Current ratio
3.40
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
NASDAQ Global Select
Employees
4,427
IPO date
1995-08-16
Headquarters
Princeton, NJ, US
About Integra LifeSciences Holdings Corporation

Integra LifeSciences Holdings Corporation is a medical technology company focused on the creation, production, and global distribution of advanced surgical implants and instruments. These products are utilized across various medical fields, including neurosurgery, limb reconstruction, and general surgical procedures. The company operates through two primary business segments: Codman Specialty Surgical and Tissue Technologies. The Codman Specialty Surgical division offers a comprehensive range of neurosurgical and neuro-critical care products. This includes specialized equipment for tissue ablation, dural repair solutions, cerebral spinal fluid management systems, intracranial monitoring tools, and cranial stabilization devices. Additionally, this segment provides surgical headlamps, various instrumentation, and supports these offerings with asset management software, technical assistance, and after-market services. Integra also supplies an extensive catalog of approximately 40,000 surgical instrument designs, along with a wide selection of surgical and lighting products. Its clientele spans hospitals, surgical centers, and extends to dental, podiatry, and veterinary practices. The Tissue Technologies segment specializes in innovative regenerative technology products for the treatment of both acute and chronic wounds. It further provides surgical tissue repair solutions for a multitude of applications, such as hernia repair, peripheral nerve protection and regeneration, and tendon reconstruction. This encompasses a broad array of offerings for skin and wound repair, plastic and reconstructive surgery products, bone grafting materials, and specialized nerve and tendon repair products. Integra LifeSciences distributes its diverse product portfolio internationally, reaching markets throughout the United States, Europe, Asia Pacific, and other global regions. Distribution is managed directly through its dedicated sales forces and various other channels, serving a wide array of healthcare entities including hospitals, integrated health networks, group purchasing organizations, individual clinicians, surgery centers, and other healthcare providers. Founded in 1989, Integra LifeSciences Holdings Corporation is headquartered in Princeton, New Jersey.

Comparable companies

Integra LifeSciences Holdings Corporation is most often compared with the following Healthcare names:

BCAXBFLYEYPTFTREINMDMRVIMYGNPACBSEPNTNDM
More research on IART
IART technical analysis IART TheEdge Score Compare against peers
Open full interactive analysis & DCF →